194 related articles for article (PubMed ID: 21803956)
21. Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck.
Borucki RB; Neskey DM; Lentsch EJ
Laryngoscope; 2018 Apr; 128(4):885-888. PubMed ID: 28988458
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study.
Adami HO; Tsaih S; Lambe M; Hsieh C; Adami J; Trichopoulos D; Melbye M; Glimelius B
Int J Cancer; 1997 Jan; 70(2):155-8. PubMed ID: 9009153
[TBL] [Abstract][Full Text] [Related]
23. Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study.
Bertrand KA; Shingala J; Evens A; Birmann BM; Giovannucci E; Michaud DS
Int J Cancer; 2017 Mar; 140(5):1020-1026. PubMed ID: 27861844
[TBL] [Abstract][Full Text] [Related]
24. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.
McKenna DB; Stockton D; Brewster DH; Doherty VR
Br J Cancer; 2003 Jan; 88(1):74-8. PubMed ID: 12556962
[TBL] [Abstract][Full Text] [Related]
25. Survival patterns among lymphoma patients with a family history of lymphoma.
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
[TBL] [Abstract][Full Text] [Related]
26. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
Nieters A; Łuczyńska A; Becker S; Becker N; Vermeulen R; Overvad K; Aleksandrova K; Boeing H; Lagiou P; Trichopoulos D; Trichopoulou A; Krogh V; Masala G; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Jeurnink SM; Weiderpass E; Ardanaz E; Chirlaque MD; Sánchez MJ; Sánchez S; Borgquist S; Butt S; Melin B; Späth F; Rinaldi S; Brennan P; Kelly RS; Riboli E; Vineis P; Kaaks R
Carcinogenesis; 2014 Dec; 35(12):2716-22. PubMed ID: 25269801
[TBL] [Abstract][Full Text] [Related]
27. Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Zheng T; Blair A; Zhang Y; Weisenburger DD; Zahm SH
J Occup Environ Med; 2002 May; 44(5):469-74. PubMed ID: 12024692
[TBL] [Abstract][Full Text] [Related]
28. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
29. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
[TBL] [Abstract][Full Text] [Related]
31. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
[TBL] [Abstract][Full Text] [Related]
32. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?
Bloom R; Amber KT; Nouri K
Australas J Dermatol; 2016 Aug; 57(3):e114-6. PubMed ID: 25801041
[TBL] [Abstract][Full Text] [Related]
33. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
Pinnix CC; Osborne EM; Chihara D; Lai P; Zhou S; Ramirez MM; Oki Y; Hagemeister FB; Rodriguez AM; Samaniego F; Fowler N; Romaguera JE; Turturro F; Fayad L; Westin JR; Nastoupil L; Neelapu SS; Cheah CY; Dabaja BS; Milgrom SA; Smith GL; Horace P; Milbourne A; Wogan CF; Ballas L; Fanale MA
JAMA Oncol; 2016 Aug; 2(8):1065-9. PubMed ID: 27227654
[TBL] [Abstract][Full Text] [Related]
34. MFH of bone and osteosarcoma show similar survival and chemosensitivity.
Jeon DG; Song WS; Kong CB; Kim JR; Lee SY
Clin Orthop Relat Res; 2011 Feb; 469(2):584-90. PubMed ID: 20559764
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
Sanchez-Gonzalez B; Peñalver FJ; Medina A; Guillén H; Calleja M; Gironella M; Arranz R; Sebastian E; de Oña R; Cánovas A; de la Fuente I; Grande C; Sancho JM; Perez R; Domingo E; Lopez-Lorenzo JL; Prieto E; Panizo C; Gorosquieta A; Perez I; Cervera JM; Marin M; Mencha C; Ramila E; Salar A
Leuk Res; 2012 Jun; 36(6):709-14. PubMed ID: 22154023
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
37. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Slager SL; Benavente Y; Blair A; Vermeulen R; Cerhan JR; Costantini AS; Monnereau A; Nieters A; Clavel J; Call TG; Maynadié M; Lan Q; Clarke CA; Lightfoot T; Norman AD; Sampson JN; Casabonne D; Cocco P; de Sanjosé S
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):41-51. PubMed ID: 25174025
[TBL] [Abstract][Full Text] [Related]
38. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
Tallarico M; Foster JC; Seisler D; Lafky JM; Hurria A; Jatoi A; Cohen HJ; Muss HB; Bartlett N; Cheson BD; Jung SH; Leonard JP; Byrd JC; Nabhan C
J Geriatr Oncol; 2018 Jul; 9(4):321-328. PubMed ID: 29673807
[TBL] [Abstract][Full Text] [Related]
39. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.
Brånvall E; Ekberg S; Eloranta S; Wästerlid T; Birmann BM; Smedby KE
Br J Haematol; 2021 Nov; 195(4):552-560. PubMed ID: 34331461
[TBL] [Abstract][Full Text] [Related]
40. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]